Retrospective Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Aug 26, 2022; 10(24): 8556-8567
Published online Aug 26, 2022. doi: 10.12998/wjcc.v10.i24.8556
Table 3 Univariate and multivariate analysis for postoperative complications
Variables
Univariate analysis
P value
Multivariate analysis
P value
OR (95%CI)
OR (95%CI)
Age1.00 (0.93-1.08)0.864
Sex0.85 (0.50-1.46)0.562
ASA
1NANA
20.51 (0.28-0.93)0.027
3Ref.1
49.53 (1.26-72.1)0.029
BMI0.92 (0.85-1.01)0.072
CCI0.82 (0.43-1.600.611
Prior upper abdomen surgery0.79 (0.36-1.72)0.559
Leucocytes1.00 (1.00-1.00)0.009
Platelets1.00 (1.00-1.00)0.0131.00 (1.00-1.00)0.0008
Bilirubin1.23 (0.97-1.57)0.081
C-reactive protein1.00 (0.99-1.00)0.195
Antiplatelet1.33 (0.77-2.31)0.311
Anticoagulant therapy1.922 (0.96-3.85)0.065
Acute cholecystitis Tokyo grade
Mild1.55 (0.67-3.35)0.324
Moderate2.19 (1.11-4.32)0.023
Severe4.54 (2.00-10.3)0.0003
BIliary colic3.43 (1.70-6.93)0.0006
Biliary pancreatitis1.24 (0.51-3.04)0.635
Gallbladder cancer1.95 (0.22-17.1)0.543
Choleperitoneum1.61 (0.58-4.45)0.36
Cholangitis12.0 (1.59-89.7)0.01912.7 (1.61-100.1)0.016
Preoperative ERCP0.38 (0.16-0.91)0.03
Admission-surgery interval1.04 (0.95-1.14)0.326
Laparoscopy0.28 (0.11-0.69)0.0050.10 (0.02-0.46)0.003
Conversion to open surgery1.81 (0.37-1.42)0.354
Choledocholithotomy1.07 (0.33-3.46)0.914
Intraoperative cholangiography2.12 (1.23-3.64)0.0072.99 (1.43-6.24)0.003
Intraoperative ERCP1.47 (0.57-3.78)0.423
Transcystic biliary decompression2.57 (0.73-8.95)0.138
Afternoon night procedure2.12 (1.21-3.74)0.009